Arterial remodeling of pulmonary circulation in salt-fed Dahl R and Dahl S rats

M. Jackel, T. Kerenyi, G. Simon (Budapest, Hungary; Minneapolis, MN, United States Of America)

Source: Annual Congress 2007 - Pulmonary circulation
Session: Pulmonary circulation
Session type: Thematic Poster Session
Number: 2113
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Jackel, T. Kerenyi, G. Simon (Budapest, Hungary; Minneapolis, MN, United States Of America). Arterial remodeling of pulmonary circulation in salt-fed Dahl R and Dahl S rats. Eur Respir J 2007; 30: Suppl. 51, 2113

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of leptin and endothelin-1
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013

TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Pulmonary vasoreactivity to leptin in spontaneously hypertensive rats
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015


Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010

MiR-1-5p targets TGF-ßR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats
Source: Eur Respir J 2005; 26: Suppl. 49, 291s
Year: 2005

VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009



Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Pulmonary vein banding-induced pulmonary venous congestion causes pulmonary hypertension in rats.
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021

Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary hypertension in rats
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008

Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Autoradiography of hypoxia tracer in the pulmonary hypertensive rat heart
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010

Bosentan fails to prevent the development of pulmonary arterial hypertension in athymic rats exposed to chronic hypoxia
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010


Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats
Source: Eur Respir J 2011; 37: 813-822
Year: 2011



Effect of roflumilast on hypoxia- and monocrotaline-induced pulmonary hypertension in rats
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Endothelium in pulmonary arterial hypertension
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (5) 2003914; 10.1183/13993003.03914-2020
Year: 2021



Zamicastat decreases cardiac arrhythmias in a rat model of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


LATE-BREAKING ABSTRACT: KCNK3 dysfunction contributes to the development of pulmonary arterial hypertension – Characterization of Kcnk3 deficient rats
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016


Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats
Source: Eur Respir J 2011; 37: 1104-1118
Year: 2011